FF
UTHR icon

FourThought Financial’s United Therapeutics UTHR Stock Holding History

FourThought Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$8K Hold
40
– – ﹤0.01% 1096
2022
Q2 		$9K Hold
40
– – ﹤0.01% 1050
2022
Q1 		$7K Hold
40
– – ﹤0.01% 1130
2021
Q4 		$9K Hold
40
– – ﹤0.01% 1096
2021
Q3 		$7K Hold
40
– – ﹤0.01% 1177
2021
Q2 		$7K Hold
40
– – ﹤0.01% 1173
2021
Q1 		$6K Hold
40
– – ﹤0.01% 1156
2020
Q4 		$6K Buy
+40
New +$5.25K ﹤0.01% 1121

Other funds holding UTHR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FourThought Financial's UTHR Position: Q3 2022 in Review

FourThought Financial held its United Therapeutics (UTHR) position steady in Q3 2022 at 40 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

FourThought Financial first reported a position in UTHR in Q4 2020 and has held it in 8 quarters since. The position peaked at $9K in Q2 2022. 461 funds tracked by Wall St. Rank hold UTHR as of Q3 2022.

  • FourThought Financial held 40 shares of United Therapeutics worth $8K as of Q3 2022.
  • FourThought Financial left its United Therapeutics share count unchanged in Q3 2022.
  • United Therapeutics made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1096 holding.
  • FourThought Financial first reported a position in United Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's United Therapeutics position peaked at $9K in Q2 2022.
  • 461 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.